NTP taps disinfection by-products for study. by Booker, S M
NIEHS News
NTPTaps
Disinfection
By-Products -
forStudy
The use of chlorination to purify water
supplies is considered one of the most
important public health advances of the
twentieth century. Following the 1908
introduction ofwidespread water chlorina-
tion, once-common diseases such as cholera,
dysentery, and typhoid fever were practically
eliminated. However, the chlorination cure-
all proved to have a caveat: disinfection by-
products (DBPs), which result from the
reaction between the chlorine added during
chlorination and organic material such as
leaves and sediment in the source water. In
the mid-1970s, certain DBPs were found to
cause adverse health effects induding cancer
in laboratoryanimals.
In November 1992, in accordance with
the Safe Drinking Water Act, the U.S.
Environmental Protection Agency (EPA)
convened a committee consisting of repre-
sentatives from state and local regulatory
and public health agencies, local govern-
ment, consumer groups, public water sy
tems, environmental groups, and
itself to address the issue of r
in drinking water. The co
that more information edBPs
before final legislation l , so a
two-stage rule was-enaed,
The stage 1 DBP nded as an
interim rule to get soe rk in place,
was promulgae in hr 1998. Based
on the best avail ence, the rule set
maximimum con ant level goals or
maximum resid nfectant level goals
for over 20 DB DBP mixtures. The
final stage 2 D is due by May 2002.
There are, how ill insufficient data for
scientists and llators to establish DBP
standards with confidence.
To fill in the missing data, the EPA's
Office of Water and National Health and
Environmental Effects Research Laboratory
(NHEERL) established a research program
for mechanistic research on DBPs and
turned to the National Toxicology Program
(NTP) for its expertise in evaluating envi-
ronmental chemicals. Together, the EPA
and the NTP are systematically evaluating
several priority DBPs in order to give policy
makers the information they need to set
sound drinking waterstandards.
The DBP Dilemma
The most commonly occurring DBPs are
the trihalomethanes (THMs) and the
haloacetic acids (HAAs). Other chlo- I _ rination DBPs include afamilyof
chemicals called the haloacetoni-
triles and acompQund known as
mutagenX(MX).
In 1976 the National Cancer
Institute issued its Report on the
Carcinogenic Bioassay ofChloroform,
which stated that chloroform, the
THM found most commonly and in the
greatest concentrations in drinking water,
causes cancer in rodents. Since
then, additional studies
have shown that
other chlorination(
DBPs such as j
bromodichloro- N
methane, chloro-
dibromomethane,
bromoform, and
dichloroacetic acid
also cause cancer in
rodents. A study by
Kenneth P. Cantor
and colleagues at
theNational Cancer
Institute, published
in the December
1987 issue of the
Journal of the
N4tional Cancer
,Institute, found that
people who drank 8
cups of chlorinated
tap water for 40-59
years had a 40%
greater risk of blad-
der cancer than those
who drank less tap
water or unchlorinat-
ed water. People w2
drank 8 cups ofchlo-
rinated tap water for
60 or more years had
an 80% greater risk
of bladder cancer.
Although cigarette
smoking and occupation-
al exposure to carcinogens _
remain the primary causes of
bladder cancer, the study scientists
said, THMs in drinking water cannot be
discounted as acontributing factor.
Chlorination isn't the only disinfection
process that yields DBPs, however.
Alternatives to chlorine disinfection-which
inc4ide the use of chlorine dioxide, ozone,
an ruination-produce their own
y of which can cause
adve i rodents and,
possibly, luim ,Ie
dioxide to drinkinga c ate du
chlorate. (Currently, there are few toxicity
data on sodium chlorate.) Treatment with
ozone causes few DBPs but does result in
the production of bromate when used in
water with high bromine concentrations.
Bromate has been shown in studies by the
EPA to cause mesotheliomas in rats and kid-
ney tumors in both rats and mice. In addi-
tion, oral exposures to potassium bromate
have been shown to cause renal cancer in
rats. Finally, chloramination, the addition
of both chlorine and ammonia to drink-
ing water, reduces the incidence ofTHMs
but produces chlo-
ramines, which in
high doses cause
N blood and liver
J damage in labo-
4 ratory animals.
The effects of
chloramines on
humans are cur-
rently unknown.
According to
Gary Boorman,
associate direc-
tor of the NTP
Office ofSpecial
Programs and
coordinator of
7 DBP studies at
the NIEHS, ol
one-third of peo-
ple's exposure to
DBPs comes
1 through drinking
water (including
its use with cof-
fee, tea, and foods
such as juice
concentrates and
instant soups).
People are also
exposed dermally
and inhalationally
through activities
such as cooking,
bathing, swimming
in pools, and using
-~ dishwashers and
;4~ 7-, humidifiers. Because it
is difficult to avoid DBP
exposure, it is crucial that scientists
understandtheeffectsofthesechemicals. How-
ever,it'shardtoaccuratelymeasurehowmuch
DBP one is exposed to because the occur-
rence and concentration of a particular by-
product ishighlydependent on themethod
ofdisinfection usedandothervariablessuch
as the amountoforganicmatpegi4d wer
the temperatureoftheisw f AMfin 7f
n.
For each compound studied, the NTP col-
aborators are examining some combination
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of carcinogenicity, reproductive toxicity,
neurotoxicity, and immunotoxicity, with
molecular biology studies to follow up in
selected areas. The NTP is using both tradi-
tional rodent models and transgenic mice to
conduct long- and short-term toxicity stud-
ies. In addition, program scientists led by
James Burkhart, chief of the Alternative
Test Systems Group in the Laboratory of
Toxicology, are working with the Depart-
ment of Defense under the supervision of
Hank Gardner, scientific director of the
U.S. ArmyCenterfor Environmental Health
Research at Fort Detrick, Maryland, to eval-
uate the effects oflow doses ofchloroform,
chlorate, and bromodichloromethane in the
Japanese medaka (Oryzias latipes), a small
fish model. Because standard rodent models
are not always responsive to every DBP,
especially at low concentrations, study plan-
ners hope the transgenic models and the
medaka can help determine the effects and
toxicity ofindividual DBPs and DBP mix-
tures atlowconcentrations.
Chemistry. The chemistry of the DBPs
is complex, especially at low concentrations.
Chemistry Resources Group leader Cynthia
Smith is responsible for ensuring that in all
NTP studies the animals are exposed to
DBP concentrations according to each study
design. This includes procuring the purest
available material, characterizing the purity
and identity ofeach DBP, developing repro-
ducible techniques for formulation and
chemical analysis, and verifying their sta-
"bility in tap water. Most of the chemicals
were available commercially, but bromodi-
chloroacetic acid and MX were synthesized
forthesestudies.
In collaboration with the NTP, scien-
tists from the NIEHS, the EPA, and the
Chemical Industry Institute ofToxicology
(CIIT) are conducting studies to determine
the blood and tissue levels ofDBPs in both
humans and rodents following drinking
water, dermal, and inhalation exposures. In
these toxicokinetic studies, human volun-
teers are exposed at concentrations typically
found in drinking water while the rodents
are exposed at much higher concentrations.
;_; Toxicokineticstudieswillbeusefulinextrap-
olating the results from rodent studies to
estimate possible hazards for humans
exposed at the much lower concentrations
found in drinkingwater.
Carcinogenicity. Long-term rodent
carcinogenicity studies are being developed
for six compounds under Boorman's direc-
tion and one compound (MX) under the
direction of Ronald A. Herbert of the
Pathology Support Group in the Laboratory
ofExperimental Pathology. The studies will
focus on low-dose exposures to the various
compounds. Boorman explains that doses of
DBPs found to cause cancer in rodents in
past studies were as much as 200,000-
400,000 times higher than the concentra-
tions typically found in drinking water, so
it is important to characterize the effects of
the concentrations that people realistically
are more likely to encounter.
Bromodichloromethane, a THM, had
been found to cause colon, kidney, and liver
tumors in rodents in previous NTP studies.
Further NTP studies will look at the effects
of lower doses on the intestines, kidneys,
and liver in rats and mice, transgenic mice,
and the medaka. NTP researcher June
Dunnick is also evaluating bromodichloro-
methane in a transgenic mouse model with
a mutated APC tumor suppressor gene that
is specifically sensitive to the development
ofintestinal cancer. Because bromodichloro-
methane exposure mayalso occur by inhala-
tion, the NIEHS is collaborating with the
CIIT on bromodichloromethane inhalation
studies usingtransgenic mice.
Dibromoacetic acid, an HAA, was
selected forstudy because it occurs frequent-
ly and there are far fewer toxicology data on
this compound than on other HAAs. Based
on evidence that kindred compounds
trichloroacetic acid and dichloroacetic acid
(which is also being studied further) cause
liver cancer in rodents at 0.5 grams per liter
andhigher, scientists expect that liver tumors
may be associated with exposure to high
concentrations ofdibromoacetic acid aswell.
Studies are also being planned for bro-
modichloroacetic acid, one ofthe brominat-
ed HAAs, which (based on preliminary
data) are suspected ofbeing more toxic than
their chlorinated HAA sisters. There is prac-
tically no information on the haloacetoni-
trile family ofDBPs, so dibromoacetonitrile
was chosen for study as a representative for
the group. Based on the results ofthis evalu-
ation, other compounds in the family may
be tested later.
Chlorate, produced by the alternative
disinfectant chlorine dioxide, has not been
extensively tested for toxicity data, but it is
known that high doses ofchlorate can cause
methemoglobinemia ("blue babysyndrome")
and blood cell destruction. Preliminary evi-
dencebytheDepartmentofDefense suggests
that the medaka may be quite insensitive to
chlorate, while NTP and EPA studies sug-
gest that rats but not mice develop thyroid
follicular cell hyperplasia when exposed to
highchlorateconcentrations. Studiesto deter-
mine the mechanistic underpinnings for this
hyperplasia are underway in a collaborative
effort between NIEHS and EPA scientists.
Bromate, produced during ozonation and
shown to cause cancer in standard rodent
studies, is being testedextensively. The NTP
will study the effects ofsodium bromate in
transgenic mouse models and, dependingon
the results, furtherstudies maybe planned.
MX, which has been shown to cause
thyroid and liver tumors in rats, is being
considered forstudies in both rats and mice.
Although it occurs at relatively low concen-
trations in drinking water, MX is believed
to cause as much as 50% ofthe mutagenici-
tyassociatedwith chlorinated tapwater.
Reproductive toxiity. Robert Chapin, a
reproductive toxicologist in the Laboratory
ofToxicology, is responsible for studies on
10 compounds identified as high priorities
by the EPA: the THMs bromodichloro-
methane and chlorodibromomethane; the
HAAs bromochloroacetic acid, dibro-
mochloroacetic acid, and tribromoacetic
acid; the haloacetonitriles bromoacetonitrile
and dibromoacetonitrile; hexachloro-
propanone (a member of a lesser class of
DBPs called the haloketones); sodium bro-
mate; and a mixture ofmono-, di-, and tri-
chloroaceticacids, mono-anddibromoacetic
acids,andbromochloroaceticacid(all HAAs).
Chapin has completed studies on the
nine individual compounds using a short-
term (21-day) screen that allows researchers
to test for a wide range of reproductive,
developmental, and general toxicity end
points in parallel groups rather than serial-
ly, as they normallywould be. According to
Chapin, the first nine studies did not reveal
any striking reproductive or general toxici-
ties. "There were palatability problems long
before there were significant toxicities," he
says, meaning that the chemicals made the
water taste too bad to drink before any
toxic concentrations were reached. The
team is now down to the last test, the big
mixture. Chapin says of the reproductive
toxicity tests, "They don't cover effects on
animals once they've grown up, which is to
say, what we were primarily interested in
were the effects on the parents-can they
make babies successfully and do those
babies seem healthy? The whole endocrine
disruptor issue has refocused our attention
on the question of 'if a kid looks healthy,
will it still be healthy when it grows up-
can it find a mate? Can it ward off infec-
tions?"' In future studies, Chapin and col-
leagues will be looking notjust at reproduc-
tive toxicity but also neurotoxicity and
immunotoxicity all in one cohort of ani-
mals exposed either during development or
during gestation and development.
Neurotoxicity. Recently, Ginger Moser
and colleagues at the NHEERL studied the
neurotoxicity of dichloroacetic acid and
published their results in the November-
December 1999 issue of Neurotoxicology
and Teratology. They found that exposure
to very low doses ofdichloroacetic acid-as
low as 16 milligrams per kilogram ofbody
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weight per day-caused progressive neu-
ropathy in the limbs (primarily the hind
limbs) of rats. The neuropathy manifested
as limb weakness, altered gait and righting
reflex, reduced grip strength, tremors, and
an unusual claspingofthe front paws to the
chest. The rats also experienced ocular
abnormalities including loss ofpupil reflex.
Although earlier studies had noted neuro-
toxic effects in rats upon exposure to
dichloroacetic acid, the EPA/NTP study
was the first to show these effects at such
lowdoses.
Based on the strength ofthose findings,
Moser and colleagues at the NTP decided
to study additional DBPs. Currently, they
are studying the neurotoxicity of dibro-
moacetic acid, and Moser expects these
studies to yield interesting results. She says,
"Dibromoacetic acid is very similar to di-
chloroacetic acid chemically; reproductive
studies show that it affects sperm even more
strongly than dichloroacetic acid does."
Collaborative studies on bromodichloro-
methane and dibromoacetonitrile are also in
the works. To Moser's knowledge, no one
has ever studied the neurotoxicity of DBPs
other than dichloroacetic acid.
Jean Harry, chief of the Neurotoxicity
Group in the Laboratory ofToxicology, is
coordinating the efforts between the EPA
and the NIEHS. "We're choosing chemi-
cals to study based on their interest in neu-
rotoxicity," she says. She emphasizes that
the studies are meant to evaluate subtle
effects that may manifest. "We're not
expecting any particular type of effect;
we're doing a broad screen for whatever
neurobehavioral end points may be affect-
ed," she says. The studies will use the
Functional Observational Battery (FOB),
the standard multinationally validated test-
ing battery recommended by the EPA for
chemical and pesticide screening.
Immunotoxicity. Dori Germolec is
chief of the Immunotoxicity Group in the
Laboratory of Toxicology. She oversees a
contract with Virginia Commonwealth
University in Richmond in which dibro-
moacetic acid, dichloroacetic acid, sodium
bromate, and sodium chlorite (used during
treatment with chlorine dioxide) are being
tested for immunologic effects. These com-
pounds were selected for study by the
Office ofWater based on historical reports
that theyexhibit some immunologic effects.
Germolec's group will also be studying
chloramine and chloroform.
Each of the first four compounds has
undergone a screening study in which widely
spaced dose levels were used to identify
whether there appeared to bean immune tar-
get. Identification of an immune target
wouldqualifyacompoundforafuill protocol
studyto further identifythespecific cell types
orarm ofthe immune system targeted by the
compound, says Germolec. She says that
sodium bromate andsodium chlorite showed
no immunologic effects and will undergo no
further testing. Dichloroacetic acid exhibited
weak, statisticallyinsignificant effects.
Dibromoacetic acid, however, was shown
to cause significant immune effects. When
administered in drinking water at doses of
125-2,000 milligrams per liter, the com-
pound induced dose-dependent effects
including changes in organ weights, blood
count parameters, and numbers ofantibody-
producing spleen cells. The most marked
effect was observed in the 500-milligrams-
per-liter dose group, which experienced a
20% increase in spleen cell number com-
pared to control animals. Based on the
results ofthis preliminarystudy, a full proto-
col study of dibromoacetic acid has been
launchedand iscurrentlyin progress.
Molecular biology. Robert Sills, chiefof
the Molecular Pathology Group in the
Laboratory ofExperimental Pathology, and
Harry will pick up where the neurotoxicity
and carcinogenicity studies leave off.
Specifically, their work will provide mecha-
nistic data for characterizing the toxicity of
carcinogenic DPBs at the molecular level.
For compounds that induce a tumor
response, Sills will examine genetic alter-
ations in the rodent tumors. "An under-
standing ofthe mechanism of the toxicity
and of carcinogenicity will allow for a
better understanding of the relevance of
animal data to humans," he says. He
explains that genes altered in human
tumors have counterparts in the rodent
genome that are likely to be the genes
affected in rodent tumors. By identifying
whether the rodent gene alterations corre-
spond with known human cancer mecha-
nisms, it may be possible to better estimate
whether a compound is likely to also cause
tumors in humans.
In following up on the neurotoxicity
evaluations, Sills and Harry will be looking
at components of both the peripheral and
central nervous systems related to effects
that may be seen in the neurobehavioral
screening battery conducted by Moser. For
instance, in the dichloroacetic acid studies
in which rats suffered hind limb weakness,
they will study the parts ofthe nervous sys-
tem that innervate the hind limbs including
the sciatic nerve, associated motor system
areas in the spinal cord, and the cerebellar
region ofthe brain in orderto identifycellu-
lar changes. "We will look histopathologi-
cally at areas that are identified as suspicious
in the FOB," says Harry.
AComplexIsue
Today, the EPA is seeking to minimize the
potential health effects due to DBPs while
still protecting the public water supply
against microbial pathogens. Because DBP
productiondependssoheavilyon thephysical
characteristics of the water itself, Boorman
says water utility companies can help reduce
DBPs by changing the pH and other charac-
teristics ofthe water during the chlorination
process. One planned benefit ofthe ongoing
research on DBPs is an ability to advisewater
utilities on altering their techniques without
compromisingwaterquality.
One of the primary issues in DBP
evaluation is the need to balance risks and
benefits-the risks ofDBPs versus the risks
ofnonchlorinated water. Boorman cites the
example ofa cholera epidemic that began in
1991 in Chancay, Peru, after authorities
decided to discontinue water chlorination
following reports that DBPs presented a
cancer risk to humans. By the end of 1992,
the epidemic had spread throughout Latin
America, and Peru alone suffered some
350,000 cases. (Many Peruvian localities
have since resumed water chlorination.)
Although the EPA stated in 1992 that there
was no demonstrable link between DBPs
andcancerinhumans,concernsremaintoday.
A new concern about DBPs is that as
water temperatures rise in response to global
warming, the amount oforganic material in
the water also rises-and the more organic
material there is in the water, the more
DBPs can be produced. Boorman says there
has been a reported increase in blue-green
algal blooms. He wants to find out how
prevalent the blooms are and study the
effects of blue-green algae toxins (micro-
cystins) onwaterquality.
Boorman also notes that humans are
more often exposed to complex mixtures of
DBPs and other water contaminants at very
low concentrations than to single chemicals.
In addition, most of the data available are
for chlorination by-products because this
has traditionally been the water disinfection
method of choice in the United States,
although alternative disinfectants are being
used more widely. In order to make sound
policy decisions regarding water treatment,
it is necessary to have more information on
the relative risks ofthe different disinfection
processes as well as information on the
extent of exposures to DBP mixtures-
information that is notyetavailable.
Drinkingwatersafetyis a complex issue,
says Boorman. "Drinkingwater issues are so
big and complex that no one agencyhas the
resources and information to address them,"
he says. "It's in everyone's best interest to
worktogether." -Susan M. Booker
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